Product & Service Providers in: COMPOUNDING: USP <797> & <800> Sterile Resouces, Compliance, Technology SOFTWARE: Drug Diversion Monitoring, Diversion Prevention As Seen In: View ARL

USP 797 has minimum standards that are the framework of sterile compounding. However, many facets of sterile compounding are not covered in 797 or are

Bracketing and Its Application to Quality Testing Bracketing is a testing design approach recognized by USP, FDA, and ICH for assessing the quality of pharmaceutical

What is stability? The extent to which a product or preparation retains physical and chemical properties and characteristics within specified limits throughout its expiration or

Nicole Vu, PhD, Scientific Director, ARL Bio Pharma Compounding with synthetic peptides Therapeutic peptides are biosimilar molecules, composed of a-amino acid (AA) polymer with a

The United States Pharmacopeia requires each facility to have a designated person for chapters 795, 797, 800, and 825. This role is vital to maintaining

Speaker: Andrew Taylor, ARL Bio Pharma Microbiology Supervisor This presentation discusses requirements for sterility testing as per USP 71 and 797. Attendees gain detailed insights

Ensure your health-system’s compounded drug products and facilities consistently meet quality standards. Company Background ARL Bio Pharma is a contract laboratory that provides analytical and